The real-life clinical effects of 52 weeks of omalizumab therapy for severe persistent allergic asthma
Crossref DOI link: https://doi.org/10.1007/s11096-014-0034-7
Published Online: 2014-11-14
Published Print: 2015-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Gouder, Caroline
West, Lorna Marie
Montefort, Stephen
Text and Data Mining valid from 2014-11-14